U.S. Magnetic Resonance Imaging Industry

The U.S. magnetic resonance imaging market size is expected to reach USD 2.6 billion in 2030, registering a CAGR of 6.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increase in chronic disorder, rise in geriatric patients, need for improved diagnostic tools, and the rise for minimally invasive diagnostic tools are the factors accountable for the market growth. An increased number of research activities to develop hybrid systems like PET/MRI, growing installations of 7.0T MRI for its precise imaging quality, and promising outcomes of magnetic resonance imaging (MRI) in critical application areas such as dentistry are the additional factors responsible for the growth of the market.

Only 30 institutes in the U.S. have installed 7.0T MRI systems that affirm its ability to produce high-quality neuroimages. GE Healthcare received FDA clearance for its 7.0T MRI scanners to produce clear and accurate images of the brain and joint micro-vasculature to detect various neurological disorders such as Alzheimer’s disease and mild traumatic brain injury. Additionally, these novel systems are the platforms for imaging the knee and cartilage.

Further, these systems showed promising results in the detection of neurological conditions of the patients post-COVID-19. Thus, these techniques improve patient satisfaction, eases radiologists’ workflow, and reduced rescan frequencies. Additionally, researchers in the University of Minnesota are developing ultra-high field scanners up to 20 T for the operation of human imaging. Such research activities create market growth opportunities in the coming years.

The outbreak of COVID-19 led to a decline in research activities, the closure of universities along with academic institutions, and a decline in clinical trial activities. The fear of virus spread also declined any diagnostic or surgical activities at the end-use settings. The economic crunch at hospitals, diagnostic centers or clinics, led to the reduced adoption of systems used for the diagnosis. Thus, the pandemic led to a decline in the market during 2020.

Gather more insights about the market drivers, restrains and growth of the U.S. Magnetic Resonance Imaging market

U.S. Magnetic Resonance Imaging Market Segments Highlights:

• The open system is anticipated to be the fastest-growing segment during the forecast period
• MRI for neurological and brain disorders dominated the market largely due to the growing number of neurological conditions and the increased geriatric population
• The high-field MRI segment is expected to experience the fastest growth largely due to its efficiency to provide detailed images for the diagnosis
• Imaging centers are expected to exhibit the highest growth rate during the forecast period

U.S. Magnetic Resonance Imaging Market Report Segmentation

Grand View Research has segmented the U.S. magnetic resonance imaging market report based on architecture, field strength, application, and end-use:

U.S. MRI Architecture Outlook (Revenue, USD Million, 2018 - 2030)

• Closed System
• Open System

U.S. MRI Field Strength Outlook (Revenue, USD Million, 2018 - 2030)

• Low Field Strength
• Mid Field Strength
• High Field Strength

U.S. MRI Application Outlook (Revenue, USD Million, 2018 - 2030)

• Obstructive Sleep Apnea (OSA)
• Brain And Neurological
• Spine And Musculoskeletal
• Vascular
• Abdominal
• Cardiac
• Breast
• Other

U.S. MRI End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Imaging Centers
• Ambulatory Surgical Centers
• Others

Key U.S. Magnetic Resonance Imaging Company Insights

• GE Healthcare
• Siemens AG
• Toshiba Corporation
• Aurora Imaging Technologies, Inc.
• Koninklijke Philips N.V.
• Esaote SPA
• Sanrad Medical Systems Pvt ltd
• Fujifilm

Order a free sample PDF of the U.S. Magnetic Resonance Imaging Market Intelligence Study, published by Grand View Research.